AIM
BDSI

Acrospire Investment Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Acrospire Investment Management’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-7,750
Closed -$22K – 2088
2017
Q2 		$22K Buy
+7,750
New +$16.4K 0.02% 1489
2017
Q1 		– Sell
-12,420
Closed -$22K – 2728
2016
Q4 		$22K Buy
12,420
+6,214
+100% +$12.7K 0.01% 1738
2016
Q3 		$17K Buy
+6,206
New +$15.8K 0.01% 1567

Other funds holding BDSI

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

Acrospire Investment Management's BDSI Position: Q3 2017 in Review

Acrospire Investment Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q3 2017, closing a stake of 7,750 shares — an estimated $22K sold.

Acrospire Investment Management first reported a position in BDSI in Q3 2016 and held it in 3 quarters. The position peaked at $22K in Q2 2017. 62 funds tracked by Wall St. Rank hold BDSI as of Q3 2017.

  • Acrospire Investment Management reported no remaining BioDelivery Sciences International, Inc. position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 7,750 BioDelivery Sciences International, Inc. shares in Q3 2017, an estimated $22K.
  • Acrospire Investment Management first reported a position in BioDelivery Sciences International, Inc. in Q3 2016 and held it in 3 quarters.
  • Acrospire Investment Management's BioDelivery Sciences International, Inc. position peaked at $22K in Q2 2017.
  • 62 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.